Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-010
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Re-appointment of 2026 Audit Firm
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or significant omissions.
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the Second Meeting of the Ninth Board of Directors on April 21, 2026, and approved the "Proposal on Re-appointing the 2026 Audit Firm." It was agreed to re-appoint Lixin Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Lixin") as the Company's audit firm for 2026, and to submit it for review at the Company's 2025 Annual Shareholders' Meeting. The relevant matters are hereby announced as follows:
I. Explanation of the Proposed Appointment of the Audit Firm
Lixin possesses audit qualifications for securities and futures businesses, has extensive experience and professional ethics in auditing listed companies, and can effectively meet the Company's requirements for establishing and improving internal controls and financial auditing. During its tenure as the Company's audit firm, Lixin has been diligent and responsible, adhering to relevant regulations such as the "Chinese Certified Public Accountants Independent Auditing Standards," upholding independent, objective, and fair auditing principles, and issuing fair and reasonable audit opinions. It has diligently fulfilled its duties as an audit firm, effectively safeguarding the legitimate rights and interests of the Company and its shareholders. Based on Lixin's extensive auditing experience and professional ethics, it can provide high-quality audit services to the Company while maintaining the continuity of audit work. The Company's Board of Directors proposes to re-appoint Lixin as the Company's audit firm for 2026, with a term of one year.
II. Basic Information of the Proposed Re-appointed Audit Firm
(I) Institutional Information
- Basic Information
Lixin was founded by Dr. Pan Xulun, a renowned Chinese accounting scholar, in Shanghai in 1927. It was re-established in 1986 and became the first special general partnership accounting firm in China to complete its restructuring in 2010. Its registered address is in Shanghai, and its chief partner is Mr. Zhu Jiandi. Lixin is a member of the international accounting network BDO and has long been engaged in securities service business. Prior to the implementation of the new Securities Law, it held securities and futures business licenses and has H-share audit qualifications. It has also registered with the Public Company Accounting Oversight Board (PCAOB) in the United States.